Stockholders' Equity (Details)
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
|
|
|
|
|
Mar. 25, 2025
USD ($)
$ / shares
shares
|
Mar. 11, 2025
USD ($)
$ / shares
shares
|
Sep. 16, 2024
USD ($)
$ / shares
|
Sep. 05, 2024
USD ($)
$ / shares
shares
|
Feb. 20, 2024
USD ($)
$ / shares
shares
|
Nov. 30, 2023
USD ($)
$ / shares
shares
|
Jul. 24, 2023
USD ($)
|
Jul. 16, 2023
$ / shares
|
May 04, 2023
USD ($)
|
Apr. 30, 2022
USD ($)
$ / shares
shares
|
Feb. 02, 2022
shares
|
Jan. 10, 2022
shares
|
Nov. 30, 2023
$ / shares
shares
|
Jun. 30, 2023
$ / shares
shares
|
Apr. 30, 2022
$ / shares
shares
|
Mar. 31, 2025
USD ($)
$ / shares
shares
|
Mar. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2024
$ / shares
shares
|
Feb. 18, 2024
$ / shares
shares
|
Aug. 31, 2021
shares
|
Jul. 31, 2021
shares
|
Apr. 30, 2021
shares
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
130,000,000
|
|
130,000,000
|
|
|
|
|
Common stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
|
Aggregate gross sales price (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,990,000
|
|
|
|
|
|
Conversion rate, description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i) up to 12,500 shares of common stock, if the closing sale price of its common stock on Nasdaq on such business
day is at least $15.00 per share and (ii) up to 15,000 shares of common stock, if the closing sale price of its common stock on Nasdaq
on such business day is at least $25.00 per share
|
|
|
|
|
|
|
Warrant term |
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
|
|
|
Fair value of warrant grant date (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,164
|
|
|
|
|
|
|
|
|
Fair value of per warrant grant date (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
12.64
|
|
|
|
|
|
|
|
|
Fair value price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 24
|
|
|
|
|
|
|
|
|
Daily return rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
5.18%
|
|
|
|
|
|
|
|
|
Short-term annual volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
Standard deviation |
|
|
|
|
|
|
|
|
|
|
|
|
|
6.30%
|
|
|
|
|
|
|
|
|
2025 Warrant Inducement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
$ 1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other transaction expenses (in Dollars) | $ |
|
$ 2,735,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series C-1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
$ 1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
2,445,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
|
$ 0.97
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
$ 1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
1,222,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series C-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
$ 1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
1,222,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
|
$ 0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued offering warrants (in Shares) | shares |
|
|
|
|
32,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock and Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued offering warrants (in Shares) | shares |
|
|
|
|
19,637
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion shares (in Shares) | shares |
|
|
|
|
84,729
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IPO Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
$ 400
|
|
|
|
|
$ 400
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
1,200
|
|
|
|
|
1,200
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 220
|
|
|
|
|
|
|
|
Fair value of warrants (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
$ 264,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant grant date (in Dollars per share) |
|
|
|
|
|
|
|
$ 25.168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 Offering Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
207,484
|
|
|
|
|
|
|
Convertible Note Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
|
|
$ 10.32
|
|
|
|
|
|
|
$ 10.32
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
|
|
|
|
5,625
|
|
|
|
|
|
|
5,625
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
Common stock exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.52
|
|
|
|
|
|
|
|
|
|
Fair value of warrants (in Dollars) | $ |
|
|
|
|
|
$ 58,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
|
$ 4.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
|
|
|
51,937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants (in Dollars) | $ |
|
|
|
|
$ 254,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series B Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued offering warrants (in Shares) | shares |
|
|
|
16,214
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
|
|
|
$ 2.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants (in Dollars) | $ |
|
|
|
$ 37,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
|
|
$ 5.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance cost (in Dollars) | $ |
|
|
$ 1,222,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series B New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
$ 4.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
|
|
$ 4.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series C Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other transaction expenses (in Dollars) | $ |
|
$ 2,735,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series D Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
733,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
$ 2.72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series E Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
1,271,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted (in Dollars per share) |
$ 2.72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
62.55
|
|
|
|
60
|
62.55
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series C-1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series C-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Convertible Note Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
68.89
|
|
|
|
|
|
|
68.89
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series A Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
68.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series B Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series A New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series B New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series D Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Volatility [Member] | Series E Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
68.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
0
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series C-1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series C-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Convertible Note Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
0
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series A Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series B Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series A New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series B New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series D Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend Yield [Member] | Series E Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
2.92
|
|
|
|
3.99
|
2.92
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series C-1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series C-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Convertible Note Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
4.41
|
|
|
|
|
|
|
4.41
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series A Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
4.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series B Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
3.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series A New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series B New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series D Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free Interest Rate [Member] | Series E Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
4.9
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series C-1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series C-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Convertible Note Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
5
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series A Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series B Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series A New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series B New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series D Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Term [Member] | Series E Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
130,000,000
|
|
|
|
Common stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
Issuance of shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140,430
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
Percentage of shares issued to stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
Common Stock [Member] | Series A Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
|
$ 4.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Series B Preferred Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
$ 4.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Series A New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
$ 4,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Series B New Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance cost (in Dollars) | $ |
|
|
$ 1,222,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000,000
|
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
2025 Securities Purchase Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of shares (in Shares) | shares |
1,271,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
1,271,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other transaction expenses (in Dollars) | $ |
$ 1,234,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share (in Dollars per share) |
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 Securities Purchase Agreements [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of shares (in Shares) | shares |
733,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of warrant shares (in Shares) | shares |
733,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share (in Dollars per share) |
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from preferred stock and warrants (in Dollars) | $ |
|
|
|
|
$ 2,437,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At-the-Market Offering Program [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate gross sales price (in Dollars) | $ |
|
|
|
|
|
|
|
|
$ 5,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of gross proceeds |
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At-the-Market Offering Program [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock sold (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
129,199
|
|
|
|
|
|
Price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 14.63
|
|
|
|
|
|
Net proceeds (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 1,834,000
|
|
|
|
|
|
2012 Plan [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered offering units shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
737,516
|
662,516
|
2022 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of gross proceeds |
|
|
|
|
|
|
|
|
|
|
4.00%
|
|
|
|
|
|
|
|
|
|
|
|
Common stock sold (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
1,100,000
|
1,100,000
|
|
|
|
|
|
|
|
|
|
|
Issuance of shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73,196
|
|
|
|
|
|
|
Percentage of outstanding shares |
|
|
|
|
|
|
|
|
|
|
|
4.00%
|
|
|
|
|
|
|
|
|
|
|
2022 Plan [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock sold (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
1,600,000
|
1,600,000
|
|
|
|
|
|
|
|
|
|
|
Lincoln Park Capital Fund, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
Share price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.5
|
|
|
|
|
|
|
Equity Line of Credit [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds (in Dollars) | $ |
|
|
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
Purchase exceed amount (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000,000
|
|
|
|
|
|
|
Purchase of shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
Percentage of outstanding shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.99%
|
|
|
|
|
|
|
Equity Line of Credit [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 8.9
|
|
|
|
|
|
Net proceeds (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 95,000
|
|
|
|
|
|
Equity Line of Credit [Member] | At-the-Market Offering Program [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock sold (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
11,231,000
|
|
|
|
|
|
Purchase Agreement [Member] | Series B Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued offering warrants (in Shares) | shares |
|
|
|
16,214
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock exercise price (in Dollars per share) |
|
|
|
$ 4.2756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate offering price (in Dollars) | $ |
|
|
|
$ 489,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum [Member] | 2012 Plan [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered offering units shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
737,516
|
|
|
Maximum [Member] | 2012 Plan [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered offering units shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
799,266
|
|
|
Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,500,000
|
|
4,500,000
|
4,500,000
|
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
|
$ 4.2756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of series A preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
the product of (x) $15.125 multiplied by (y) the sum of 1 plus the product of (A) 0.06 multiplied by (B) a fraction
equal to the number of days that such share of Series A Preferred Stock has been issued divided by 365. “Conversion Price”
means (i) for the shares of Series A Preferred Stock issued on the Closing Date, $1.5125 and (ii) for each share of Series A Preferred
Stock issued thereafter, an amount equal to the greater of (x) $1.5125 and the average of the VWAPs for the 10 Trading Days prior the
issuance date of such share of Series A Preferred Stock, in each case subject to adjustment as set forth herein. On any date that ten
out of the last 15 daily VWAPs of the Common Stock is 250% higher than the Conversion Price on such date, then the Company will have the
right to require 50% of the Preferred Stock to be converted into shares of Common Stock. Additionally, on and after the time on which
the Company has $2.25 million in revenues in any single financial quarter, the Company will have the right to require 50% of the Preferred
Stock to be converted into shares of Common Stock (a “Required Conversion”). No dividends are payable on the Series A Preferred
Stock. The Series A Preferred Stock will vote together with the Common Stock on all matters other than as required by law; provided however
that any additional shares underlying the Series A Preferred Stock as a result of the anti-dilution provision described below shall not
vote on an “as converted” basis and shall only vote when issued upon conversion. Notwithstanding the foregoing, the vote of
an individual holder of Series A Preferred Stock (and underlying Common Stock) shall be capped at 9.99% (or 4.99% if selected by the holder).
|
|
|
|
|
|
|
Deemed liquidation percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110.00%
|
|
|
|
|
|
|
Increased percentage of deemed liquidation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
Indebtedness single transaction (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
Series A Preferred Stock [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) |
|
|
|
|
$ 4.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock [Member] | Merger Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
491,222
|
|
491,222
|
491,222
|
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
|
Percentage of shares issued to stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
Deemed liquidation percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110.00%
|
|
|
|
|
|
|
Increased percentage of deemed liquidation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
Indebtedness single transaction (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
Description of series B preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
the product of (x) $6.3625 multiplied by (y) the sum of 1 plus the product of (A) 0.06 multiplied by (B) a fraction
equal to the number of days that such share of Series B Preferred Stock has been issued divided by 365. “Conversion Price”
means $5.09 per share, subject to adjustment as set forth herein. On any date that ten out the last 15 daily VWAPs of the Common Stock
is 250% higher than the Conversion Price on such date, then the Company will have the right to require 50% of the Preferred Stock to be
converted into shares of Common Stock. Additionally, on and after the time on which the Company has $2.25 million in revenues in any single
financial quarter, the Company will have the right to require 50% of the Preferred Stock to be converted into shares of Common Stock (a
“Required Conversion”). No dividends are payable on the Series B Preferred Stock. The Series B Preferred Stock will vote together
with the Common Stock on all matters other than as required by law; provided however that any additional shares underlying the Series
B Preferred Stock as a result of the anti-dilution provision described below shall not vote on an “as converted” basis and
shall only vote when issued upon conversion. Notwithstanding the foregoing, the vote of an individual holder of Series B Preferred Stock
(and underlying Common Stock) shall be capped at 9.99% (or 4.99% if selected by the holder).
|
|
|
|
|
|
|
Series B Preferred Stock [Member] | Merger Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
Series B Preferred Stock [Member] | Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of shares (in Shares) | shares |
|
|
|
86,454
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock and Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of shares (in Shares) | shares |
|
|
|
|
172,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Financing Transaction, Cost [Member] | 2025 Securities Purchase Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other transaction expenses (in Dollars) | $ |
$ 2,290,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|